Health Policy News
Featured News
A paper co-authored by Stanford Law School’s Michelle Mello examines policies that health-care organizations are implementing to address potential risks associated with cognitive and physical decline in late-career physicians (LCPs).
Michelle Mello, a professor of law and of health policy, wins the annual teaching award at Stanford Law School, where her students call her an inspirational leader and committed mentor.
According to the co-authors of a perspective published in the New England Journal of Medicine, the use of AI diagnostic tools by medical practitioners can lead to unexpected financial burdens for their patients.
Stanford Health Policy's Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care in this Q&A with The Regulatory Review.
The Supreme Court ended its 2024 term with major rulings affecting federal agencies. SHP’s Michelle Mello writes in a JAMA viewpoint that while these rulings have critical ramifications for health agencies, the outlook is more complex than it might appear.
SHP's Michelle Mello and colleagues find that the most impactful court-imposed restrictions on health orders during the pandemic were in two key areas: orders that restricted religious activities, and actions taken by state and federal agencies.
Michelle Mello and colleagues argue that state legal reforms have exacerbated rather than improved weaknesses in U.S. emergency powers revealed by COVID-19, jeopardizing future responses.
In her testimony before the U.S. Senate Finance Committee, Mello emphasized the need for federal guardrails and standards regarding the use of artificial intelligence in health care.
Research led by SHP’s Michelle Mello provides some clarity regarding liability over AI technologies that are rapidly being introduced to health care. She and her co-author analyzed more than 800 tort cases involving both AI and conventional software in health care and non-health-care contexts to see how decisions related to AI and liability might play out in the courts.
SHP's Michelle Mello and Stanford Medicine colleagues write in the journal JAMA that President Biden's recent executive order on Artificial Intelligence could have significant implications for health-care organizations.
The Supreme Court decision concerning Title VII of the Civil Rights Act of 1964 raises new questions about the ability of private employers—including health-care organizations—to enforce vaccination requirements for employees who have religious objections. In this JAMA Health Forum commentary, Michelle Mello and colleagues consider the implications.
Michelle Mello and colleagues write in this JAMA Network Viewpoint that civic values were eroded during the COVID-19 pandemic, creating a groundswell of resistance to vaccines that have been a bedrock principle of U.S. public health policy.
In this commentary in the San Francisco Chronicle, Stanford Health Policy's Michelle Mello — professor of health policy and professor of law — shares her personal account of the year-long struggle to diagnose her husband's autoimmune disease.
ChatGPT and Physicians’ Malpractice Risk
In this JAMA Forum perspective, SHP's Michelle Mello, professor of health policy and of law, and Neel Guha, a Stanford Law School student and PhD candidate in computer science, write that medical advice from AI chatbots is not yet highly accurate, so physicians should only use these systems to supplement more traditional forms of medical guidance.
SHP's Marissa Reitsma and Michelle Mello conduct an original investigation that finds allowing the U.S. Centers for Medicare & Medicaid Services to negotiate prescription drug prices for Medicare may improve drug affordability.
Stanford's Michelle Mello and her colleague Lawrence O. Gostin at Georgetown University analyze the strains that public health emergency powers underwent during the pandemic, then propose reforms to modernize public health law. Mello then discusses the issue with Health Affairs' Editor-in-Chief Alan Weil for his "Health Podyssey" podcast.
In this JAMA Health Forum commentary, SHP's Michelle Mello and colleagues argue that the $1.7 trillion omnibus bill that Congress passed in December 2022 responds to several urgent public health needs, yet only narrowly addresses some of the critical determinants of pandemic preparedness.
A recently released report from an expert committee of the National Academies of Sciences, Engineering, and Medicine — including Stanford Law School and Department of Health Policy professor Michelle Mello and former Rosenkranz Prize winner Ami Bhatt — focuses on how wastewater monitoring has become a critical tool in the fight against infectious diseases.
A new paper by Michelle Mello and colleagues at Stanford and Yale outlines the "fair inclusion score," which ranks pharmaceutical companies on their inclusion of racial and ethnic minoritized groups, women, and the elderly in clinical trials.
Michelle Mello — a professor of heath policy and law — attended the Sept. 13 gathering at the White House to celebrate the passing of the Inflation Reduction Act 2022. She was invited for her contributions on Medicare price negotiation modeling for the landmark piece of legislation. In this Q&A, she discusses the bill's impact on health policy.
In this Q&A with Stephanie Ashe at Stanford Law, SHP's Michelle Mello — a professor of health policy and a professor of law — examines the guidance for health-care providers recently issued by the Biden Administration.
Michelle Mello writes that the overturning of Roe v. Wade — ending federal protection over a woman's right to an abortion — could also expose her personal health data in court.
Michelle Mello and Stanford colleagues win an annual award by the ABIM Foundation for a commentary that argued academics have an obligation to speak out against medical views that are contrary to science.